Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Pär Stattin"'
Autor:
Mieke Van Hemelrijck, Eugenio Ventimiglia, David Robinson, Rolf Gedeborg, Lars Holmberg, Pär Stattin, Hans Garmo
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-20 (2022)
Van Hemelrijck, M, Ventimiglia, E, Robinson, D, Gedeborg, R, Holmberg, L, Stattin, P & Garmo, H 2022, ' Population-based estimates of age and comorbidity specific life expectancy : a first application in Swedish males ', BMC medical informatics and decision making, vol. 22, no. 1, 35 . https://doi.org/10.1186/s12911-022-01766-0
Van Hemelrijck, M, Ventimiglia, E, Robinson, D, Gedeborg, R, Holmberg, L, Stattin, P & Garmo, H 2022, ' Population-based estimates of age and comorbidity specific life expectancy : a first application in Swedish males ', BMC medical informatics and decision making, vol. 22, no. 1, 35 . https://doi.org/10.1186/s12911-022-01766-0
Introduction For clinical decision-making, an estimate of remaining lifetime is needed to assess benefit against harm of a treatment during the remaining lifespan. Here, we describe how to predict life expectancy based on age, Charlson Comorbidity In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4c8eafcd088b75b9cbc9a53efb1a69
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-468382
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-468382
Autor:
Eugenio Ventimiglia, Anna Bill-Axelson, Jan Adolfsson, Markus Aly, Martin Eklund, Marcus Westerberg, Pär Stattin, Hans Garmo
Background: Little is known about disease trajectories for men with castration -resistant prostate cancer (CRPC).Objective: To create a state transition model that estimates time spent in the CRPC state and its outcomes.Design, setting, and participa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bfa42a659a3716bbbaa4cd18020f0c1
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-486335
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-486335
Autor:
Andri Wilberg Orrason, Marcus Westerberg, Peter Albertsen, Johan Styrke, David Robinson, Hans Garmo, Pär Stattin
The main aim of the study was to determine the impact of diagnostic activity and life expectancy on the lifetime risk of a prostate cancer diagnosis. We used a state transition simulation model based on Swedish population-based data to simulate life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb206a39f916b835813aef652ecab8f6
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-471669
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-471669
Autor:
Rebecka Arnsrud Godtman, Erik Persson, Oskar Bergengren, Stefan Carlsson, Eva Johansson, David Robinsson, Jonas Hugosson, Pär Stattin
Objective To investigate the association between surgeon volume and urinary incontinence after radical prostatectomy. Methods A total of 8326 men in The National Prostate Cancer Register of Sweden (NPCR) underwent robot-assisted radical prostatectomy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd67d285003d6e431a6fad884b4d9e54
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-497002
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-497002
Publikováno v:
American Journal of Epidemiology
Net survival, estimated in a relative survival (RS) or cause-specific survival (CSS) framework, is a key measure of the effectiveness of cancer management. We compared RS and CSS in men with prostate cancer (PCa) according to age and risk category, u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07f1ed0c24a0e2aab9a6bb6ca1c45e3
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-460914
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-460914
Autor:
E. Lin, Danielle Crawley, Mieke Van Hemelrijck, Jan Adolfsson, Pär Stattin, Hans Garmo, Björn Zethelius
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Background Gonadotropin Releasing Hormones agonists (GnRH), which are first line treatment for metastatic prostate cancer (PCa), increase risk of type 2 diabetes mellitus (T2DM). This study aims to quantify the association of use of GnRH with diabete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc586b9635c30fdf5848af296b0878d1
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-460220
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-460220
Autor:
Pär Stattin, Johan Styrke, Gincy George, Hanna Vikman, Hans Garmo, Rolf Gedeborg, Ingela Franck Lissbrant, Mieke Van Hemelrijck
Background: Men with prostate cancer (PCa) on gonadotropin-releasing hormone agonists (GnRH) have an increased risk of cardiovascular disease (CVD) compared to men with PCa not on GnRH as well as compared with PCa-free men. Whether the addition of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca66dd912385c1ea9f3124f526f1d9e0
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-448193
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-448193
Autor:
Fredrik Sandin, Eva Johansson, David Robinsson, Göran Ahlgren, Jonas Hugosson, Erik Persson, Stefan Carlsson, Walter Cazzaniga, Pär Stattin, Rebecka Arnsrud Godtman
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 6, p e0253081 (2021)
PLoS ONE, Vol 16, Iss 6, p e0253081 (2021)
Background and objective Few studies have investigated the association between surgical volume and outcome of robot-assisted radical prostatectomy (RARP) in an unselected cohort. We sought to investigate the association between surgical volume with p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd10c4653e8b06dbc7fe2175b1705c1c
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-452322
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-452322
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0255239 (2021)
PLoS ONE
PLoS ONE
Background The Charlson Comorbidity Index is a poor predictor of mortality in men with castration resistant prostate cancer (CRPC). To improve this prediction, we created a comorbidity index based on filled prescriptions intended to be used in regist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b32374fdb531bc2e7d9240c1750c591
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-453480
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-453480
Autor:
Hanna Vikman, Charlotte Alverbratt, Hans Garmo, Marie Eriksson, Pär Stattin, Giuseppe Fallara, Ingela Franck Lissbrant
Background There are little and inconsistent data from clinical practice on time on treatment with the androgen receptor-targeted drugs (ART) abiraterone and enzalutamide in men with metastatic castration-resistant prostate cancer (mCRPC). We assesse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edbf87e4022f901be45339d6d649710c
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-459356
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-459356